2019-11-122019-11-122016http://hdl.handle.net/10625/58281Bluetongue (BT) is an infectious, non-contagious, vector-borne viral epizootic disease that affects domestic and wild ruminants. For target countries of the Livestock Vaccine Innovation Fund (LVIF), the economic and socio impacts are felt most in India and South Africa, but there is very limited information. It is difficult to make definitive statements about losses, due to concerns regarding differential diagnosis with common diseases. A BTV-8 outbreak in France (2007) was estimated to cost $1.4 billion. Treatment of BT-affected animals involves only nonspecific supportive and nursing care. Despite the major advances in understanding and prevention, a commercial recombinant vaccine against BT remains elusive.application/pdfenDISEASE VECTORSANIMAL HEALTHEPIDEMIOLOGYVIRUSLIVESTOCKSHEEPVACCINESIMMUNIZATIONDISEASE CONTROLBLUETONGUEDISEASE TRANSMISSIONSOUTH OF SAHARASOUTH ASIABook